Aug 21, 2023Confidence A
Product0 evidence links
Genesis Therapeutics product scope reviewed
Genesis Therapeutics public product source reviewed for category placement and current operating focus.
No source evidence matched to this event.Status timeline
Funding, product, customer, team, and correction signalsAug 21, 2023Confidence A
Funding0 evidence links
Genesis Therapeutics capital or status signal reviewed
Genesis Therapeutics public source reviewed for capital or strategic-status timeline signal.
No source evidence matched to this event.Funding timeline
Amounts are shown only when disclosed and tied to evidence.Aug 21, 2023
Series B
AmountUndisclosed
InvestorsAndreessen Horowitz, Bio+Health
EvidenceConfidence A
Source evidence
Public links, short factual summaries, and trust levelsGenesis Therapeutics capital or status signal
Genesis Therapeutics · officialGenesis Therapeutics public capital or strategic-status source reviewed for stage and timeline signal.
Open sourceGenesis Therapeutics official product profile
Genesis Therapeutics official site · officialGenesis Therapeutics official source reviewed for product scope, operating focus, and category placement.
Open source